| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.08 |